期刊簡介 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Chinese Journal of Cancer Research LetPub Score 7.0
50 ratings
Rate
Reputation 8.7 Influence 5.6 Speed 7.0 | |||||||||||
期刊簡稱 | CHINESE J CANCER RES | |||||||||||
ISSN | 1000-9604 | |||||||||||
E-ISSN | 1993-0631 | |||||||||||
h-index | N.A. | |||||||||||
CiteScore | N.A. | |||||||||||
自引率 (2023-2024) | 14.30%自引率趨勢 | |||||||||||
掲載範囲 |
| |||||||||||
官方網站 | https://www.springer.com/journal/11670 | |||||||||||
在線稿件提交 | https://mc03.manuscriptcentral.com/cjcr | |||||||||||
開放訪問 | No | |||||||||||
出版商 | Springer Berlin Heidelberg | |||||||||||
主題領域 | 医学 | |||||||||||
出版國/地區 | PEOPLES R CHINA | |||||||||||
發行頻率 | 四半期刊行 | |||||||||||
創刊年 | 1988 | |||||||||||
每年文章數 | 51每年文章數趨勢 | |||||||||||
黃金OA百分比 | 94.30% | |||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| |||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | |||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1000-9604%5BISSN%5D | |||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 4.5 Month(s) | |||||||||||
競爭力 * | 來自作者的數據: About 62.5% | |||||||||||
參考鏈接 |
| |||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[Chinese Journal of Cancer Research] 的評論 | 撰寫評論 |
作者: 佐拉瓦利斯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-05 14:10:32 評論於 How many reviewers are there?(0) 讚! | 佐拉瓦利斯 |
作者: 水之小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-27 12:55:28 評論於 Excuse me, how much is the layout fee?(0) 讚! | 水之小娘子 |
作者: 龙爪之霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-20 18:50:01 評論於 Some magazines need to be edited before you can even access them without logging in to the system(0) 讚! | 龙爪之霜 |
作者: 天池玉琲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-30 12:18:19 評論於 Has the corresponding author not received the email about the submission?(0) 讚! | 天池玉琲 |
作者: 英慧小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-28 12:16:01 評論於 Wow, is it a major repair or a minor repair?(0) 讚! | 英慧小哥哥 |
作者: 震雷智美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-16 15:01:59 評論於 Research Focus: Tumor Experience Sharing: CJCR is still very powerful, although the impact factor needs to be improved temporarily, the speed is still excellent. Submitted on March 18, revised on April 3, after careful editing and polishing submitted on the 14th, and accepted on the 17th. Give a shoutout to CJCR(0) 讚! | 震雷智美 |
作者: 太山佩玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-02 15:28:24 評論於 Please translate the following paragraph into English and Japanese, and use ":" and ":" as headings: 4.026(0) 讚! | 太山佩玉 |
作者: 霸王乐珍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-07 09:15:50 評論於 What is the current impact factor of CHINESE J CANCER RES? I couldn't find it(0) 讚! | 霸王乐珍 |
作者: 佛光烨赫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-19 17:04:17 評論於 Review speed: 24.0 | Submission success rate: 5.0 Experience sharing: Do you not have a sense of belonging to any magazine? Chinese magazines are not well received, with a tendency to admire foreign ones! Is it meaningful to be classified as T1 by the China Association for Science and Technology?(0) 讚! | 佛光烨赫 |
作者: 鹤轩小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-19 08:58:21 評論於 It says there are case studies in the description, but there is no option for that type on the submission page. Does this mean you are not accepting them anymore?(0) 讚! | 鹤轩小公主 |
作者: 雨巷少年意映 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-09 23:09:23 評論於 Do you have any recent submission experience to share with CHINESE J CANCER RES?(0) 讚! | 雨巷少年意映 |
作者: 中原宇荫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-12-28 22:17:04 評論於 Chinese magazines are not good enough, always admiring foreign things!(0) 讚! | 中原宇荫 |
作者: 龙鳞凯定 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-21 20:40:29 評論於 Review speed: 1.0 | Submission hit rate: 50.0 Experience sharing: Submitted on November 16, 2018, rejected on November 21, reason being not novel enough(0) 讚! | 龙鳞凯定 |
作者: 璃月项明 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-07 23:26:42 評論於 Started submitting from December 2017, revised three times, and finally accepted in August 2018. The review process was very strict, and the reviewers examined the content in great detail. The statistician reviewer was very professional. The questions were sharp and to the point. Looking back, 10 years ago when I submitted to CJCR, it was enough to just recommend two reviewers. However, at that time the impact factor was only 0.9(0) 讚! | 璃月项明 |
作者: 中原宇荫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-01 16:48:01 評論於 Chinese magazines. Gray-market goods(0) 讚! | 中原宇荫 |
作者: 碧桃俊艾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-14 15:31:06 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 50.0 Experience Sharing: Submitted on February 27, major revisions on April 16, revised on May 10, minor revisions on June 5, revised on June 6, accepted on June 9. Currently in "awaiting to batch" status(0) 讚! | 碧桃俊艾 |
作者: 重阳嘉美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-20 17:55:43 評論於 Trashy magazines, awesome!(0) 讚! | 重阳嘉美 |
作者: 半梦大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-07 18:27:59 評論於 @2000py, how is this magazine?(0) 讚! | 半梦大叔 |
作者: Eve Faraday 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-09-10 22:57:42 評論於 Trashy magazines, nothing innovative, but totally awesome(0) 讚! | Eve Faraday |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-12-10 23:29:20 評論於 Your submission was not accepted, it was rejected outright in one month without reason(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-11-04 16:35:42 評論於 The review process for domestic magazines is the same, including the Chinese Medical Journal(0) 讚! | 凌霄高洁 |
作者: 桃花夜雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-08-25 14:26:05 評論於 Why does everyone say this magazine is rubbish?(0) 讚! | 桃花夜雪 |
作者: 形意山桃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-01-04 17:50:53 評論於 I want to say that my article has not been replied for a long time. I called and the person who answered the phone asked another person what was going on, and the other person said it was terrible. Without changing a word, I submitted it to Medical Oncology. The impact factor that year rose to 2.21. I think the thinking and direction of this journal are not right, the articles they publish are just like those translated from Chinese journals, with too many formal requirements and cannot keep up with international standards. However, foreign journals focus on different aspects, as long as there is something new and the design is reasonable, it can be published. This suggestion is for reference only(0) 讚! | 形意山桃 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-06-29 10:40:40 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: Review speed: average, not much different from other domestic journals. After minor revisions, it was directly accepted. It is a quarterly journal, and the paper will only be published half a year after acceptance. From submission, revisions, acceptance, to final publication, it took a full 10 months. Not recommended for comrades in a hurry to publish!(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-05-06 11:20:01 評論於 Procrastinating manuscript processing will eventually ruin this magazine(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us